<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35390469</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1090-2139</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Brain, behavior, and immunity</Title><ISOAbbreviation>Brain Behav Immun</ISOAbbreviation></Journal><ArticleTitle>Long COVID and long chain fatty acids (LCFAs): Psychoneuroimmunity implication of omega-3 LCFAs in delayed consequences of COVID-19.</ArticleTitle><Pagination><StartPage>19</StartPage><EndPage>27</EndPage><MedlinePgn>19-27</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbi.2022.04.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0889-1591(22)00095-2</ELocationID><Abstract><AbstractText>The global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to the lasting pandemic of coronavirus disease 2019 (COVID-19) and the post-acute phase sequelae of heterogeneous negative impacts in multiple systems known as the "long COVID." The mechanisms of neuropsychiatric complications of long COVID are multifactorial, including long-term tissue damages from direct CNS viral involvement, unresolved systemic inflammation and oxidative stress, maladaptation of the renin-angiotensin-aldosterone system and coagulation system, dysregulated immunity, the dysfunction of neurotransmitters and hypothalamus-pituitaryadrenal (HPA) axis, and the psychosocial stress imposed by societal changes in response to this pandemic. The strength of safety, well-acceptance, and accumulating scientific evidence has now afforded nutritional medicine a place in the mainstream of neuropsychiatric intervention and prophylaxis. Long chain omega-3 polyunsaturated fatty acids (omega-3 or n-3 PUFAs) might have favorable effects on immunity, inflammation, oxidative stress and psychoneuroimmunity at different stages of SARS-CoV-2 infection. Omega-3 PUFAs, particularly EPA, have shown effects in treating mood and neurocognitive disorders by reducing pro-inflammatory cytokines, altering the HPA axis, and modulating neurotransmission via lipid rafts. In addition, omega-3 PUFAs and their metabolites, including specialized pro-resolvin mediators, accelerate the process of cleansing chronic inflammation and restoring tissue homeostasis, and therefore offer a promising strategy for Long COVID. In this article, we explore in a systematic review the putative molecular mechanisms by which omega-3 PUFAs and their metabolites counteract the negative effects of long COVID on the brain, behavior, and immunity.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Chun-Pai</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Department of Neurology, Kuang Tien General Hospital, Taichung, Taiwan; Department of Nutrition, HungKuang University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Ching-Mao</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Center for Traditional Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Institute of Traditional Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Cheng-Chia</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Healthcare Administration, Asia University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pariante</LastName><ForeName>Carmine M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Kuan-Pin</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>King's College London, London, UK; Mind-Body Interface Laboratory (MBI-Lab), China Medical University Hospital, Taichung, Taiwan; College of Medicine, China Medical University, Taichung, Taiwan; An-Nan Hospital, China Medical University, Tainan, Taiwan. Electronic address: cobol@cmu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>G108/603</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/J002739/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/N029488/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Brain Behav Immun</MedlineTA><NlmUniqueID>8800478</NlmUniqueID><ISSNLinking>0889-1591</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005227">Fatty Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015525">Fatty Acids, Omega-3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015525" MajorTopicYN="Y">Fatty Acids, Omega-3</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007030" MajorTopicYN="N">Hypothalamo-Hypophyseal System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010913" MajorTopicYN="N">Pituitary-Adrenal System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cognition</Keyword><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">Immunity</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Mood</Keyword><Keyword MajorTopicYN="N">Omega-3 PUFAs</Keyword><Keyword MajorTopicYN="N">Sickness</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>7</Day><Hour>20</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35390469</ArticleId><ArticleId IdType="pmc">PMC8977215</ArticleId><ArticleId IdType="doi">10.1016/j.bbi.2022.04.001</ArticleId><ArticleId IdType="pii">S0889-1591(22)00095-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., Li W.W., Li V.W., Mentzer S.J., Jonigk D. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 2020;383(2):120&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Amato M.-K., Hennessy C., Shah K., Mayer J. Multisystem inflammatory syndrome in an adult. J. Emerg. Med. 2021;61(1):e1&#x2013;e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8026263</ArticleId><ArticleId IdType="pubmed">33838966</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson E.J., Thayne K.A., Harris M., Shaikh S.R., Darden T.M., Lark D.S., Williams J.M., Chitwood W.R., Kypson A.P., Rodriguez E. Do fish oil omega-3 fatty acids enhance antioxidant capacity and mitochondrial fatty acid oxidation in human atrial myocardium via PPARgamma activation? Antioxid. Redox Signal. 2014;21:1156&#x2013;1163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4142835</ArticleId><ArticleId IdType="pubmed">24597798</ArticleId></ArticleIdList></Reference><Reference><Citation>Belayev L., Khoutorova L., Atkins K.D., Eady T.N., Hong S., Lu Y., Obenaus A., Bazan N.G. Docosahexaenoic acid therapy of experimental ischemic stroke. Transl Stroke Res. 2011;2(1):33&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3037476</ArticleId><ArticleId IdType="pubmed">21423332</ArticleId></ArticleIdList></Reference><Reference><Citation>Belot, A., Antona, D., Renolleau, S., Javouhey, E., Hentgen, V., Angoulvant, F., Delacourt, C., Iriart, X., Ovaert, C., Bader-Meunier, B., Kone-Paut, I., Levy-Bruhl, D., 2020. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Euro Surveill 25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7336112</ArticleId><ArticleId IdType="pubmed">32524957</ArticleId></ArticleIdList></Reference><Reference><Citation>Blondeau N., Nguemeni C., Debruyne D.N., Piens M., Wu X., Pan H., Hu X., Gandin C., Lipsky R.H., Plumier J.-C., Marini A.M., Heurteaux C. Subchronic alpha-linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: a versatile potential therapy for stroke. Neuropsychopharmacology. 2009;34(12):2548&#x2013;2559.</Citation><ArticleIdList><ArticleId IdType="pubmed">19641487</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghi C., Cicero A.F. Omega-3 polyunsaturated fatty acids: Their potential role in blood pressure prevention and management. Heart Int. 2006;2:98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3184661</ArticleId><ArticleId IdType="pubmed">21977258</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder P.C. Mechanisms of action of (n-3) fatty acids. J. Nutr. 2012;142:592S&#x2013;599S.</Citation><ArticleIdList><ArticleId IdType="pubmed">22279140</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder P.C. Long chain fatty acids and gene expression in inflammation and immunity. Curr. Opin. Clin. Nutr. Metab. Care. 2013;16(4):425&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">23657154</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder P., Carr A., Gombart A., Eggersdorfer M. Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections. Nutrients. 2020;12(4):1181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7230749</ArticleId><ArticleId IdType="pubmed">32340216</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi, A., Bernabei, R., Landi, F., Gemelli Against, C.-P.-A.C.S.G., 2020. Persistent Symptoms in Patients After Acute COVID-19. JAMA 324, 603-605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmo A., Pereira&#x2010;Vaz J., Mota V., Mendes A., Morais C., Silva A.C., Camilo E., Pinto C.S., Cunha E., Pereira J., Coucelo M., Martinho P., Correia L., Marques G., Ara&#xfa;jo L., Rodrigues F. Clearance and persistence of SARS-CoV-2 RNA in patients with COVID-19. J. Med. Virol. 2020;92(10):2227&#x2013;2231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301002</ArticleId><ArticleId IdType="pubmed">32484958</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J.P., Su K.P. The lipid raft hypothesis: the relation among omega-3 fatty acids, depression, and cardiovascular diseases. Taiwan J. Psychiatry. 2010;24:168&#x2013;180.</Citation></Reference><Reference><Citation>Chang J.-C., Pariante C.M., Su K.-P. Omega-3 fatty acids in the psychological and physiological resilience against COVID-19. Prostaglandins Leukot. Essent. Fatty Acids. 2020;161:102177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7516470</ArticleId><ArticleId IdType="pubmed">33031994</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J.-C., Su K.-P., Mondelli V., Pariante C.M. Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: a systematic review and meta-analysis of clinical trials and biological studies. Neuropsychopharmacology. 2018;43(3):534&#x2013;545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5669464</ArticleId><ArticleId IdType="pubmed">28741625</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J.P., Su K.P., Mondelli V., Satyanarayanan S.K., Yang H.T., Chiang Y.J., Chen H.T., Pariante C.M. High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels. Transl. Psychiatry. 2019;9:303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6864068</ArticleId><ArticleId IdType="pubmed">31745072</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu C.-C., Su K.-P., Cheng T.-C., Liu H.-C., Chang C.-J., Dewey M.E., Stewart R., Huang S.-Y. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2008;32(6):1538&#x2013;1544.</Citation><ArticleIdList><ArticleId IdType="pubmed">18573585</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu H., Chan J.-W., Yuen T.-T., Shuai H., Yuan S., Wang Y., Hu B., Yip C.-Y., Tsang J.-L., Huang X., Chai Y., Yang D., Hou Y., Chik K.-H., Zhang X.i., Fung A.-F., Tsoi H.-W., Cai J.-P., Chan W.-M., Ip J.D., Chu A.-H., Zhou J., Lung D.C., Kok K.-H., To K.-W., Tsang O.-Y., Chan K.-H., Yuen K.-Y. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe. 2020;1(1):e14&#x2013;e23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7173822</ArticleId><ArticleId IdType="pubmed">32835326</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper S.L., Boyle E., Jefferson S.R., Heslop C.R.A., Mohan P., Mohanraj G.G.J., Sidow H.A., Tan R.C.P., Hill S.J., Woolard J. Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID. Int. J. Mol. Sci. 2021;22(15):8255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8347967</ArticleId><ArticleId IdType="pubmed">34361021</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Darwesh A.M., Bassiouni W., Sosnowski D.K., Seubert J.M. Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications? Pharmacol. Ther. 2021;219:107703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534795</ArticleId><ArticleId IdType="pubmed">33031856</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan E., Cooper K., Cowie J., Alexander L., Morris J., Preston J. A national survey of community rehabilitation service provision for people with long Covid in Scotland. F1000Res. 2020;9:1416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8063521</ArticleId><ArticleId IdType="pubmed">33953912</ArticleId></ArticleIdList></Reference><Reference><Citation>EPA-COV-001, 2020. EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2). ClinicalTrials.gov Identifier: NCT04335032.</Citation></Reference><Reference><Citation>Escardio.org, 2020. ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic.</Citation></Reference><Reference><Citation>Eslamloo K., Xue X., Hall J.R., Smith N.C., Caballero-Solares A., Parrish C.C., Taylor R.G., Rise M.L. Transcriptome profiling of antiviral immune and dietary fatty acid dependent responses of Atlantic salmon macrophage-like cells. BMC Genomics. 2017;18:706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5591513</ArticleId><ArticleId IdType="pubmed">28886690</ArticleId></ArticleIdList></Reference><Reference><Citation>Excellence, N.I.f.H.a.C., 2020. COVID-19 rapid guideline: managing the long-term effects of COVID-19 NICE guideline.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank A., Fatke B., Frank W., Forstl H., Holzle P. Depression, dependence and prices of the COVID-19-Crisis. Brain Behav. Immun. 2020;87:99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7189841</ArticleId><ArticleId IdType="pubmed">32360604</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman M.P. Omega-3 fatty acids and perinatal depression: a review of the literature and recommendations for future research. Prostaglandins Leukot. Essent. Fatty Acids. 2006;75(4-5):291&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pubmed">16930971</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S., Tokuyama M., Cho A., Jankovic M., Schaefer-Babajew D., Oliveira T.Y., Cipolla M., Viant C., Barnes C.O., Bram Y., Breton G., H&#xe4;ggl&#xf6;f T., Mendoza P., Hurley A., Turroja M., Gordon K., Millard K.G., Ramos V., Schmidt F., Weisblum Y., Jha D., Tankelevich M., Martinez-Delgado G., Yee J., Patel R., Dizon J., Unson-O&#x2019;Brien C., Shimeliovich I., Robbiani D.F., Zhao Z., Gazumyan A., Schwartz R.E., Hatziioannou T., Bjorkman P.J., Mehandru S., Bieniasz P.D., Caskey M., Nussenzweig M.C. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591(7851):639&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Goc A., Niedzwiecki A., Rath M. Polyunsaturated omega-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry. Sci. Rep. 2021;11:5207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7933164</ArticleId><ArticleId IdType="pubmed">33664446</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A'Court C., Buxton M., Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H., Guis S., Barthelemy F., Habert P., Ceccaldi M., Million M., Raoult D., Cammilleri S., Eldin C. (18)F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imaging. 2021;48(9):2823&#x2013;2833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez S., Svahn S.L., Johansson M.E. Effects of Omega-3 fatty acids on immune cells. Int. J. Mol. Sci. 2019;20:5028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6834330</ArticleId><ArticleId IdType="pubmed">31614433</ArticleId></ArticleIdList></Reference><Reference><Citation>Guu T.-W., Mischoulon D., Sarris J., Hibbeln J., McNamara R., Hamazaki K., Freeman M., Maes M., Matsuoka Y., Belmaker R.H., Jacka F., Pariante C., Berk M., Marx W., Su K.-P. International society for nutritional psychiatry research practice guidelines for omega-3 fatty acids in the treatment of major depressive disorder. Psychother. Psychosom. 2019;88(5):263&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pubmed">31480057</ArticleId></ArticleIdList></Reference><Reference><Citation>Hathaway D., Pandav K., Patel M., Riva-Moscoso A., Singh B.M., Patel A., Min Z.C., Singh-Makkar S., Sana M.K., Sanchez-Dopazo R., Desir R., Fahem M.M.M., Manella S., Rodriguez I., Alvarez A., Abreu R. Omega 3 fatty acids and COVID-19: a comprehensive review. Infect Chemother. 2020;52(4):478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7779984</ArticleId><ArticleId IdType="pubmed">33377319</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M.T., Golenbock D., Latz E., Morgan D., Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 2020;12:69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7271826</ArticleId><ArticleId IdType="pubmed">32498691</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirotsu Y., Maejima M., Shibusawa M., Amemiya K., Nagakubo Y., Hosaka K., Sueki H., Hayakawa M., Mochizuki H., Tsutsui T., Kakizaki Y., Miyashita Y., Omata M. Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection. J Infect Chemother. 2021;27(2):406&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598429</ArticleId><ArticleId IdType="pubmed">33183963</ArticleId></ArticleIdList></Reference><Reference><Citation>Horrocks L.A., Farooqui A.A. Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins Leukot. Essent. Fatty Acids. 2004;70(4):361&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pubmed">15041028</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L.i., Liu M., Zhou X., Luo J., Huang Z., Tu S., Zhao Y., Chen L.i., Xu D., Li Y., Li C., Peng L.u., Li Y., Xie W., Cui D., Shang L., Fan G., Xu J., Wang G., Wang Y., Zhong J., Wang C., Wang J., Zhang D., Cao B. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandetu T.B., Dziuban E.J., Sikuvi K., Beard R.S., Nghihepa R., van Rooyen G., Shiningavamwe A., Katjitae I. Persistence of Positive RT-PCR Results for Over 70 Days in Two Travelers with COVID-19. Disaster Med Public Health Prep. 2020:1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884651</ArticleId><ArticleId IdType="pubmed">33208199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaseda E.T., Levine A.J. Post-traumatic stress disorder: a differential diagnostic consideration for COVID-19 survivors. Clin Neuropsychol. 2020;34(7-8):1498&#x2013;1514.</Citation><ArticleIdList><ArticleId IdType="pubmed">32847484</ArticleId></ArticleIdList></Reference><Reference><Citation>Khomich O., Kochetkov S., Bartosch B., Ivanov A. Redox biology of respiratory viral infections. Viruses. 2018;10(8):392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6115776</ArticleId><ArticleId IdType="pubmed">30049972</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.A. How much &#x201c;Thinking&#x201d; about COVID-19 is clinically dysfunctional? Brain Behav. Immun. 2020;87:97&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185010</ArticleId><ArticleId IdType="pubmed">32353520</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Zheng X.-S., Shen X.-R., Si H.-R., Wang X.i., Wang Q.i., Li B., Zhang W., Zhu Y., Jiang R.-D., Zhao K., Wang H., Shi Z.-L., Zhang H.-L., Du R.-H., Zhou P. Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19. Emerg Microbes Infect. 2020;9(1):2571&#x2013;2577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7734137</ArticleId><ArticleId IdType="pubmed">33196399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin P.-Y., Chiu C.-C., Huang S.-Y., Su K.-P. A meta-analytic review of polyunsaturated fatty acid compositions in dementia. J. Clin. Psychiatry. 2012;73(09):1245&#x2013;1254.</Citation><ArticleIdList><ArticleId IdType="pubmed">22938939</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin P.-Y., Huang S.-Y., Su K.-P. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol. Psychiatry. 2010;68(2):140&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">20452573</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Wu D., Ni N., Ren H., Luo C., He C., Kang J.X., Wan J.B., Su H. Omega-3 polyunsaturated fatty acids protect neural progenitor cells against oxidative injury. Mar. Drugs. 2014;12:2341&#x2013;2356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4052293</ArticleId><ArticleId IdType="pubmed">24786451</ArticleId></ArticleIdList></Reference><Reference><Citation>Llach C.D., Vieta E. Mind long COVID: Psychiatric sequelae of SARS-CoV-2 infection. Eur. Neuropsychopharmacol. 2021;49:119&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8098059</ArticleId><ArticleId IdType="pubmed">33992951</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci. Rep. 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Lordan R., Redfern S., Tsoupras A., Zabetakis I. Inflammation and cardiovascular disease: are marine phospholipids the answer? Food Funct. 2020;11(4):2861&#x2013;2885.</Citation><ArticleIdList><ArticleId IdType="pubmed">32270798</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu D.-Y., Tsao Y.-Y., Leung Y.-M., Su K.-P. Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for omega-3 fatty acids. Neuropsychopharmacology. 2010;35(11):2238&#x2013;2248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3055314</ArticleId><ArticleId IdType="pubmed">20668435</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C., Ren H., Wan J.-B., Yao X., Zhang X., He C., So K.-F., Kang J.X., Pei Z., Su H. Enriched endogenous omega-3 fatty acids in mice protect against global ischemia injury. J. Lipid Res. 2014;55(7):1288&#x2013;1297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4076077</ArticleId><ArticleId IdType="pubmed">24875538</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza, M.G., De Lorenzo, R., Conte, C., Poletti, S., Vai, B., Bollettini, I., Melloni, E.M.T., Furlan, R., Ciceri, F., Rovere-Querini, P., group, C.-B.O.C.S., Benedetti, F., 2020. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav. Immun. 89, 594-600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Messina G., Polito R., Monda V., Cipolloni L., Di Nunno N., Di Mizio G., Murabito P., Carotenuto M., Messina A., Pisanelli D., Valenzano A., Cibelli G., Scarinci A., Monda M., Sessa F. Functional role of dietary intervention to improve the outcome of COVID-19: a hypothesis of work. Int. J. Mol. Sci. 2020;21(9):3104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7247152</ArticleId><ArticleId IdType="pubmed">32354030</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael-Titus A. Omega-3 fatty acids: their neuroprotective and regenerative potential in traumatic neurological injury. Clin. Lipidol. 2009;4(3):343&#x2013;353.</Citation></Reference><Reference><Citation>Morris S.B., Schwartz N.G., Patel P., Abbo L., Beauchamps L., Balan S., Lee E.H., Paneth-Pollak R., Geevarughese A., Lash M.K., Dorsinville M.S., Ballen V., Eiras D.P., Newton-Cheh C., Smith E., Robinson S., Stogsdill P., Lim S., Fox S.E., Richardson G., Hand J., Oliver N.T., Kofman A., Bryant B., Ende Z., Datta D., Belay E., Godfred-Cato S. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection &#x2013; United Kingdom and United States, March-August 2020. MMWR Morb. Mortal. Wkly Rep. 2020;69(40):1450&#x2013;1456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7561225</ArticleId><ArticleId IdType="pubmed">33031361</ArticleId></ArticleIdList></Reference><Reference><Citation>MRC-04-20-1120, 2020. Omega-3 Oil Use in COVID-19 Patients in Qatar. ClinicalTrials.gov Identifier: NCT04836052.</Citation></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., Ahluwalia N., Bikdeli B., Dietz D., Der-Nigoghossian C., Liyanage-Don N., Rosner G.F., Bernstein E.J., Mohan S., Beckley A.A., Seres D.S., Choueiri T.K., Uriel N., Ausiello J.C., Accili D., Freedberg D.E., Baldwin M., Schwartz A., Brodie D., Garcia C.K., Elkind M.S.V., Connors J.M., Bilezikian J.P., Landry D.W., Wan E.Y. Post-acute COVID-19 syndrome. Nat. Med. 2021;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalleballe K., Reddy Onteddu S., Sharma R., Dandu V., Brown A., Jasti M., Yadala S., Veerapaneni K., Siddamreddy S., Avula A., Kapoor N., Mudassar K., Kovvuru S. Spectrum of neuropsychiatric manifestations in COVID-19. Brain Behav. Immun. 2020;88:71&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7297688</ArticleId><ArticleId IdType="pubmed">32561222</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A. Long-Haul COVID. Neurology. 2020;95(13):559&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pubmed">32788251</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization, W.H., 2021. COVID-19 clinical management: living guidance.</Citation></Reference><Reference><Citation>Park S.-K., Lee C.-W., Park D.-I., Woo H.-Y., Cheong H.S., Shin H.C., Ahn K., Kwon M.-J., Joo E.-J. Detection of SARS-CoV-2 in Fecal Samples From Patients With Asymptomatic and Mild COVID-19 in Korea. Clin. Gastroenterol. Hepatol. 2021;19(7):1387&#x2013;1394.e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7286243</ArticleId><ArticleId IdType="pubmed">32534042</ArticleId></ArticleIdList></Reference><Reference><Citation>Park Y., Harris W. EPA, but not DHA, decreases mean platelet volume in normal subjects. Lipids. 2002;37(10):941&#x2013;946.</Citation><ArticleIdList><ArticleId IdType="pubmed">12530552</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B.D., Lemle M.D., Komaroff A.L., Snyder S.H. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl. Acad. Sci. U. S. A. 2021:118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao J.S., Ertley R.N., Lee H.-J., DeMar J.C., Arnold J.T., Rapoport S.I., Bazinet R.P. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol. Psychiatry. 2007;12(1):36&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">16983391</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichard R.R., Kashani K.B., Boire N.A., Constantopoulos E., Guo Y., Lucchinetti C.F. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020;140(1):1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7245994</ArticleId><ArticleId IdType="pubmed">32449057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren H., Luo C., Feng Y., Yao X., Shi Z., Liang F., Kang J.X., Wan J.B., Pei Z., Su H. Omega-3 polyunsaturated fatty acids promote amyloid-beta clearance from the brain through mediating the function of the glymphatic system. FASEB J. 2017;31:282&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">27789520</ArticleId></ArticleIdList></Reference><Reference><Citation>Reshi M.L., Su Y.-C., Hong J.-R. RNA viruses: ROS-mediated cell death. In. J. Cell Biol. 2014;2014:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4034720</ArticleId><ArticleId IdType="pubmed">24899897</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie K., Chan D., Watermeyer T. The cognitive consequences of the COVID-19 epidemic: collateral damage? Brain Commun. 2020;2:fcaa069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314157</ArticleId><ArticleId IdType="pubmed">33074266</ArticleId></ArticleIdList></Reference><Reference><Citation>Rius B., Lopez-Vicario C., Gonzalez-Periz A., Moran-Salvador E., Garcia-Alonso V., Claria J., Titos E. Resolution of inflammation in obesity-induced liver disease. Front. Immunol. 2012;3:257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3422856</ArticleId><ArticleId IdType="pubmed">22934096</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson J.G., Ijioma N., Harris W. Omega-3 fatty acids and cognitive function in women. Womens Health (Lond.) 2010;6(1):119&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2826215</ArticleId><ArticleId IdType="pubmed">20088735</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogero M., Calder P. Obesity, inflammation, toll-like receptor 4 and fatty acids. Nutrients. 2018;10(4):432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5946217</ArticleId><ArticleId IdType="pubmed">29601492</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-S&#xe1;nchez C.M., D&#xed;az-Maroto I., Fern&#xe1;ndez-D&#xed;az E., S&#xe1;nchez-Larsen &#xc1;., Layos-Romero A., Garc&#xed;a-Garc&#xed;a J., Gonz&#xe1;lez E., Redondo-Pe&#xf1;as I., Perona-Moratalla A.B., Del Valle-P&#xe9;rez J.A., Gracia-Gil J., Rojas-Bartolom&#xe9; L., Feria-Vilar I., Monteagudo M., Palao M., Palaz&#xf3;n-Garc&#xed;a E., Alcahut-Rodr&#xed;guez C., Sopelana-Garay D., Moreno Y., Ahmad J., Segura T. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020;95(8):e1060&#x2013;e1070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin R. As their numbers grow, COVID-19 &#x201c;long haulers&#x201d; stump experts. JAMA. 2020;324:1381&#x2013;1383.</Citation><ArticleIdList><ArticleId IdType="pubmed">32965460</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan C.N., Arita M., Hong S., Gotlinger K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids. 2004;39(11):1125&#x2013;1132.</Citation><ArticleIdList><ArticleId IdType="pubmed">15726828</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008;8(5):349&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2744593</ArticleId><ArticleId IdType="pubmed">18437155</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Z., Ren H., Luo C., Yao X., Li P., He C., Kang J.-X., Wan J.-B., Yuan T.-F., Su H. Enriched Endogenous Omega-3 Polyunsaturated Fatty Acids Protect Cortical Neurons from Experimental Ischemic Injury. Mol. Neurobiol. 2016;53(9):6482&#x2013;6488.</Citation><ArticleIdList><ArticleId IdType="pubmed">26611833</ArticleId></ArticleIdList></Reference><Reference><Citation>Siso-Almirall, A., Brito-Zeron, P., Conangla Ferrin, L., Kostov, B., Moragas Moreno, A., Mestres, J., Sellares, J., Galindo, G., Morera, R., Basora, J., Trilla, A., Ramos-Casals, M., On Behalf Of The, C.L.C.-S.G., 2021. Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management. Int J Environ Res Public Health 18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8073248</ArticleId><ArticleId IdType="pubmed">33923972</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., Ptacek R., Ptackova H., Martin A., Kream R.M. Selective neuronal mitochondrial targeting in SARS-CoV-2 infection affects cognitive processes to induce 'brain fog' and results in behavioral changes that favor viral survival. Med. Sci. Monit. 2021;27:e930886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7845145</ArticleId><ArticleId IdType="pubmed">33487628</ArticleId></ArticleIdList></Reference><Reference><Citation>Su K.-P., Huang S.-Y., Chiu T.-H., Huang K.-C., Huang C.-L., Chang H.-C., Pariante C.M. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial. J. Clin. Psychiatry. 2008;69(4):644&#x2013;651.</Citation><ArticleIdList><ArticleId IdType="pubmed">18370571</ArticleId></ArticleIdList></Reference><Reference><Citation>Su K.-P., Lai H.-C., Yang H.-T., Su W.-P., Peng C.-Y., Chang J.-C., Chang H.-C., Pariante C.M. Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial. Biol. Psychiatry. 2014;76(7):559&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pubmed">24602409</ArticleId></ArticleIdList></Reference><Reference><Citation>Su K.P., Tseng P.T., Lin P.Y., Okubo R., Chen T.Y., Chen Y.W., Matsuoka Y.J. Association of use of Omega-3 polyunsaturated fatty acids with changes in severity of anxiety symptoms: a systematic review and meta-analysis. JAMA Netw Open. 2018;1:e182327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6324500</ArticleId><ArticleId IdType="pubmed">30646157</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S.H., Chen Q., Gu H.J., Yang G., Wang Y.X., Huang X.Y., Liu S.S., Zhang N.N., Li X.F., Xiong R., Guo Y., Deng Y.Q., Huang W.J., Liu Q., Liu Q.M., Shen Y.L., Zhou Y., Yang X., Zhao T.Y., Fan C.F., Zhou Y.S., Qin C.F., Wang Y.C. A mouse model of SARS-CoV-2 infection and pathogenesis. Cell Host Microbe. 2020;28 124-133 e124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250783</ArticleId><ArticleId IdType="pubmed">32485164</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N., Bai H., Chen X., Gong J., Li D., Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemost. 2020;18:1094&#x2013;1099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9906401</ArticleId><ArticleId IdType="pubmed">32220112</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Luciano S., Geddes J.R., Harrison P.J. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8:130&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>USnews.com, 2021. CDC expected to release guidance on identifying, managing long COVID.</Citation></Reference><Reference><Citation>Vibholm L.K., Nielsen S.S.F., Pahus M.H., Frattari G.S., Olesen R., Andersen R., Monrad I., Andersen A.H.F., Thomsen M.M., Konrad C.V., Andersen S.D., Hojen J.F., Gunst J.D., Ostergaard L., Sogaard O.S., Schleimann M.H., Tolstrup M. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. EBioMedicine. 2021;64</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7847186</ArticleId><ArticleId IdType="pubmed">33530000</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivar-Sierra A., Araiza-Macias M.J., Hernandez-Contreras J.P., Vergara-Castaneda A., Ramirez-Velez G., Pinto-Almazan R., Salazar J.R., Loza-Mejia M.A. In silico study of polyunsaturated fatty acids as potential SARS-CoV-2 spike protein closed conformation stabilizers: epidemiological and computational approaches. Molecules. 2021;26</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7866518</ArticleId><ArticleId IdType="pubmed">33573088</ArticleId></ArticleIdList></Reference><Reference><Citation>von Weyhern C.H., Kaufmann I., Neff F., Kremer M. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes. Lancet. 2020;395:e109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272176</ArticleId><ArticleId IdType="pubmed">32505222</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Kream R.M., Stefano G.B. Long-term respiratory and neurological sequelae of COVID-19. Med. Sci. Monit. 2020;26:e928996.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7643287</ArticleId><ArticleId IdType="pubmed">33177481</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.C., Su K.P., Pariante C.M. The three frontlines against COVID-19. Brain Behav. Immun. 2021;93:409&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857976</ArticleId><ArticleId IdType="pubmed">33548496</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Huang K., Jiang H., Hua L., Yu W., Ding D., Wang K., Li X., Zou Z., Jin M., Xu S. Long-term existence of SARS-CoV-2 in COVID-19 patients: host immunity, viral virulence, and transmissibility. Virol Sin. 2020;35:793&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7644793</ArticleId><ArticleId IdType="pubmed">33156486</ArticleId></ArticleIdList></Reference><Reference><Citation>Wostyn P. COVID-19 and chronic fatigue syndrome: is the worst yet to come? Med. Hypotheses. 2021;146</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836544</ArticleId><ArticleId IdType="pubmed">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Guo C., Tang L., Hong Z., Zhou J., Dong X., Yin H., Xiao Q., Tang Y., Qu X., Kuang L., Fang X., Mishra N., Lu J., Shan H., Jiang G., Huang X. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol. Hepatol. 2020;5:434&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158584</ArticleId><ArticleId IdType="pubmed">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444&#x2013;1448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z., Yang M., Lai C.L. Long COVID-19 syndrome: a comprehensive review of its effect on various organ systems and recommendation on rehabilitation plans. Biomedicines. 2021;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394513</ArticleId><ArticleId IdType="pubmed">34440170</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem. Neurosci. 2021;12:573&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan B., Li W., Liu H., Cai X., Song S., Zhao J., Hu X., Li Z., Chen Y., Zhang K., Liu Z., Peng J., Wang C., Wang J., An Y. Correlation between immune response and self-reported depression during convalescence from COVID-19. Brain Behav. Immun. 2020;88:39&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7247486</ArticleId><ArticleId IdType="pubmed">32464158</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B.Z., Chu H., Han S., Shuai H., Deng J., Hu Y.F., Gong H.R., Lee A.C., Zou Z., Yau T., Wu W., Hung I.F., Chan J.F., Yuen K.Y., Huang J.D. SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res. 2020;30:928&#x2013;931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7399356</ArticleId><ArticleId IdType="pubmed">32753756</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Xu D., Xie B., Zhang Y., Huang H., Liu H., Chen H., Sun Y., Shang Y., Hashimoto K., Yuan S. Poor-sleep is associated with slow recovery from lymphopenia and an increased need for ICU care in hospitalized patients with COVID-19: a retrospective cohort study. Brain Behav. Immun. 2020;88:50&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7274970</ArticleId><ArticleId IdType="pubmed">32512133</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Wang S., Mao L., Leak R.K., Shi Y., Zhang W., Hu X., Sun B., Cao G., Gao Y., Xu Y., Chen J., Zhang F. Omega-3 fatty acids protect the brain against ischemic injury by activating Nrf2 and upregulating heme oxygenase 1. J. Neurosci. 2014;34:1903&#x2013;1915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3905150</ArticleId><ArticleId IdType="pubmed">24478369</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Li P., Hu X., Zhang F., Chen J., Gao Y. Omega-3 polyunsaturated fatty acids in the brain: metabolism and neuroprotection. Front. Biosci. (Landmark Ed.) 2011;16:2653&#x2013;2670.</Citation><ArticleIdList><ArticleId IdType="pubmed">21622201</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>